Increased T cell activation in BALF from children with Mycoplasma pneumoniae pneumonia

Pediatric Pulmonology

Volumn 50, Issue 8, 2015, Pages 814-819

  Guo, Li ^a   Liu, Fang ^a,b   Lu, Mei Ping ^a   Zheng, Qi ^a   Chen, Zhi Min ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Taizhou Nursing School   (China)

Author keywords

activated T cells; bronchoalveolar lavage; children; cytokine; Mycoplasma pneumoniae

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; CD3 ANTIGEN;

ARTICLE; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD69+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FOREIGN BODY ASPIRATION; HLA DR+ T LYMPHOCYTE; HUMAN; HUMAN CELL; INFLAMMATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; NEUTROPHIL COUNT; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ADOLESCENT; BRONCHOALVEOLAR LAVAGE FLUID; CASE CONTROL STUDY; CYTOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; NEUTROPHIL; PRESCHOOL CHILD;

ADOLESCENT; ANTIGENS, CD3; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MALE; NEUTROPHILS; PNEUMONIA, MYCOPLASMA; T-LYMPHOCYTES;

EID: 84936990329     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23095     Document Type: Article

References (33)

1. Atkinson TP, Balish MF, Waites KB,. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008; 32: 956-973.
2. Youn YS, Lee KY, Hwang JY, Rhim JW, Kang JH, Lee JS, Kim JC,. Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr 2010; 10: 48.
3. Sawicki GS, Lu FL, Valim C, Cleveland RH, Colin AA,. Necrotising pneumonia is an increasingly detected complication of pneumonia in children. Eur Respir J 2008; 31: 1285-1291.
4. Leonardi S, del GMM, Spicuzza L, Saporito M, Nipitella G, La Rosa M,. Lung abscess in a child with Mycoplasma pneumoniae infection. Eur J Pediatr 2010; 169: 1413-1415.
5. Waites KB, Talkington DF,. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004; 17: 697-728.
6. Suttorp N, Welte T, Marre R, editors. Community-acquired pneumonia. Basel, Switzerland: Burkhauser Verlag; 2007. 183-199 pp.
7. Quinton LJ, Jones MR, Robson BE, Simms BT, Whitsett JA, Mizgerd JP,. Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia. Am J Respir Cell Mol Biol 2008; 38: 699-706.
8. Lieberman D, Livnat S, Schlaeffer F, Porath A, Horowitz S, Levy R,. IL-1beta and IL-6 in community-acquired pneumonia: Bacteremic pneumococcal pneumonia versus Mycoplasma pneumoniae pneumonia. Infection 1997; 25: 90-94.
9. Poe SL, Arora M, Oriss TB, Yarlagadda M, Isse K, Khare A, Levy DE, Lee JS, Mallampalli RK, Chan YR, et al., STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia. Mucosal Immunol 2013; 6: 189-199.
10. Hassan J, Irwin F, Dooley S, Connell J,. Mycoplasma pneumoniae infection in a pediatric population: Analysis of soluble immune markers as risk factors for asthma. Hum Immunol 2008; 69: 851-855.
11. Jacobs E, Rock R, Dalehite L,. A B cell-, T cell-linked epitope located on the adhesin of Mycoplasma pneumoniae. Infect Immun 1990; 58: 2464-2469.
12. Tamura A, Matsubara K, Tanaka T, Nigami H, Yura K, Fukaya T,. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect 2008; 57: 223-228.
13. Rea IM, McNerlan SE, Alexander HD,. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging. Exp Gerontol 1999; 34: 79-93.
14. Chernick V, Boat TF, Wilmott RW, Bush A, Deterding RR, Ratjen FA,. Kendig's disorders of the respiratory tract in children. (7th edition). Philadelphia: 2006.
15. Subspecialty Group of Respiratory Diseases, Society of Pediatrics, Chinese Medical Association; Editorial Board, Chinese Journal of Pediatrics. Guidelines for management of childhood community acquired pneumonia (for trial implementation) (I). Chin J Pediatr Zhonghua Er Ke Za Zhi 2007; 45: 83-90.
16. Tumgor G, Celik U, Alabaz D, et al., Aetiological agents, interleukin-6, interleukin-8 and CRP concentrations in children with community- and hospital-acquired pneumonia. Ann Trop Paediatr 2006; 26: 285-291.
17. Sutherland RE, Olsen JS, McKinstry A, Villalta SA, Wolters PJ,. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J immunol 2008; 181: 5598-5605.
18. Lee YL, Chen W, Chen LY, Chen CH, Lin YC, Liang SJ, Shih CM,. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia. J Crit Care 2010; 25: 176.e7-176.e13.
19. Hsieh CC, Tang RB, Tsai CH, Chen W,. Serum interleukin-6 and tumor necrosis factor-alpha concentrations in children with mycoplasma pneumonia. J Microbiol Immunol Infect 2001; 34: 109-112.
20. Yu X, Zhang X, Zhao B, Wang J, Zhu Z, Teng Z, Shao J, Shen J, Gao Y, Yuan Z, et al., Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6. PLoS One 2011; 6: e28680.
21. Buff SM, Yu H, McCall JN, Caldwell SM, Ferkol TW, Flotte TR, Virella-Lowell IL,. IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia. Gene Ther 2010; 17: 567-576.
22. Jeong ES, Won YS, Kim HC, Cho MH, Choi YK,. Role of IL-10 deficiency in pneumonia induced by Corynebacterium kutscheri in mice. J Microbiol Biotechnol 2009; 19: 424-430.
23. Gallagher PM, Lowe G, Fitzgerald T, Bella A, Greene CM, McElvaney NG, O'Neill SJ,. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 2003; 58: 154-156.
24. Pietsch K, Ehlers S, Jacobs E,. Cytokine gene expression in the lungs of BALB/c mice during primary and secondary intranasal infection with Mycoplasma pneumoniae. Microbiology (Reading, England) 1994; 140: 2043-2048.
25. Heron M, Claessen AM, Grutters JC, van den Bosch JM,. T-cell activation profiles in different granulomatous interstitial lung diseases-a role for CD8 + CD28 (null) cells. Clin Exp Immunol 2010; 160: 256-265.
26. Trisolini R, Lazzari Agli L, Cancellieri A, Procaccio L, Candoli P, Alifano M, Patelli M,. Bronchoalveolar lavage findings in severe community-acquired pneumonia due to Legionella pneumophila serogroup 1. Respir Med 2004; 98: 1222-1226.
27. Mukae H, Kadota J, Kohno S, Matsukura S, Hara K,. Increase of activated T-cells in BAL fluid of Japanese patients with bronchiolitis obliterans organizing pneumonia and chronic eosinophilic pneumonia. Chest 1995; 108: 123-128.
28. Saetta M, Di Stefano A, Maestrelli P, Ferraresso A, Drigo R, Potena A, Ciaccia A, Fabbri LM,. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147: 301-306.
29. Hoek KL, Duffy LB, Cassell GH, Dai Y, Atkinson TP,. A role for the Mycoplasma pneumoniae adhesin P1 in interleukin (IL)-4 synthesis and release from rodent mast cells. Microb Pathog 2005; 39: 149-158.
30. Jeong YC, Yeo MS, Kim JH, Lee HB, Oh JW,. Mycoplasma pneumoniae Infection Affects the Serum Levels of Vascular Endothelial Growth Factor and Interleukin-5 in Atopic Children. Allergy Asthma Immunol Res 2012; 4: 92-97.
31. Arae K, Hirata M, Kurata S, Kamiya S, Taguchi H,. Mycoplasma pneumoniae induces interleukin-8 production via the epidermal growth factor receptor pathway. Microbiol Immunol 2011; 55: 748-750.
32. Narita M, Tanaka H,. Late increase of interleukin-18 levels in blood during Mycoplasma pneumoniae pneumonia. Cytokine 2012; 59: 18-19.
33. Chung HL, Shin JY, Ju M, Kim WT, Kim SG,. Decreased interleukin-18 response in asthmatic children with severe Mycoplasma pneumoniae pneumonia. Cytokine 2011; 54: 218-221.